We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Finding Needles in a Haystack: How One Lab Identified Random Errors in a Large Dataset

By Jen A. Miller (AACC)
Posted on 07 Jul 2023
Print article
Illustration
Illustration
Lab errors are bound to happen. A mishandled sample here, an equipment failure there—they’re usually not a big deal to fix. But infrequent random errors, especially in high-volume automated tests, can be challenging for clinical laboratorians to identify and rectify in real time. Yet doing so is critical because these problems affect patient care, over and over again.

“As much as we like to believe that errors should not occur in the clinical laboratory, they can and they do,” said Clarence Chan, MD, PhD, a clinical chemistry fellow in the department of pathology at the University of Chicago. “It’s important that we have a rational and objective approach to dealing with these kinds of situations.”

During a roundtable session at the upcoming 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, Chan will present a case study about how his team discovered and investigated random errors that were reoccuring over time. He described the errors as hard to catch even though the lab had quality-control measures in place.

“That’s the whole point of quality control, but sometimes the errors are so sporadic that you don’t always see them,” Chan said. “By coincidence, we had a few primary care doctors asking us about [a couple of results].” That kicked off an investigation into what could be causing such odd and seemingly random recurring errors.

Chan said this case is unique because of its scope–the team reviewed more than 11,000 results over a fairly long period of time–and because it required them to identify a very small fraction of spurious results within that large group. While the details of his experience won’t universally apply to other labs, he hopes participants can learn from how they solved the mystery. This process included brainstorming possible issues and systemically investigating each one until they found the root cause.

Another way labs can benefit from Chan’s insights is hearing how the team applied tools like data analysis and data informatics to their investigation.

“The goal is not to give someone an exact prescription or algorithm of how you deal with these scenarios,” he said. “Every situation will be different.” He added that his team didn’t need high-tech tools to unlock their error-causing mystery. In fact, one of the most important pieces of software they used was Microsoft Excel. “We didn’t have to do any hardcore programming, even though we handle large volumes of data. Understanding how to effectively use Excel, while also recognizing its limits and pitfalls, can also help develop an approach for using more conventional programming software such as R and Python” he said.

The roundtable will empower laboratorians with little to no prior experience in data analytics to gain confidence using large datasets in today’s increasingly digitized healthcare system. This skill is becoming even more critical, given trends towards collecting and analyzing more data across healthcare settings, including clinical laboratories. Globally, “there’s been this push for how do we get that information more efficiently and make more out of it. We’re turning out patient results all the time,” he said. “Not only are you ensuring they're accurate and precise from a technical standpoint, but when there are questions about when things go wrong, how do we get the relevant information?”

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Ultrasonic Cleaner
UC 300 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.